Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.438
+0.118 (5.09%)
At close: Dec 5, 2025
Nykode Therapeutics AS Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 796 | 995 | 6,988 | 8,287 | 23,372 | 21,356 | Upgrade
|
| Market Cap Growth | -2.87% | -85.77% | -15.67% | -64.54% | 9.44% | - | Upgrade
|
| Enterprise Value | 187 | -270 | 5,353 | 6,040 | 21,724 | 21,194 | Upgrade
|
| Last Close Price | 2.44 | 1.99 | 13.98 | 18.37 | 52.72 | 48.99 | Upgrade
|
| PE Ratio | - | - | - | - | - | 16.64 | Upgrade
|
| Forward PE | - | - | - | 4.32 | 4.32 | 4.32 | Upgrade
|
| PS Ratio | 10.85 | 9.56 | 51.73 | 93.16 | 74.18 | 11.55 | Upgrade
|
| PB Ratio | 0.80 | 0.64 | 4.02 | 5.36 | 13.67 | 13.93 | Upgrade
|
| P/TBV Ratio | 0.80 | 0.64 | 4.03 | 5.36 | 13.67 | 13.93 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 9341.31 | 13.83 | Upgrade
|
| P/OCF Ratio | - | - | - | - | 2296.91 | 13.82 | Upgrade
|
| EV/Sales Ratio | 2.54 | - | 39.62 | 67.90 | 68.94 | 11.46 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 13.87 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 13.87 | Upgrade
|
| EV/FCF Ratio | -0.52 | - | - | - | 8682.61 | 13.73 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 0.00 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 25.25 | 0.00 | Upgrade
|
| Asset Turnover | 0.05 | 0.05 | 0.06 | 0.04 | 0.14 | 1.64 | Upgrade
|
| Quick Ratio | 17.14 | 12.78 | 7.94 | 5.41 | 8.12 | 17.36 | Upgrade
|
| Current Ratio | 17.14 | 12.87 | 8.04 | 5.44 | 8.16 | 17.38 | Upgrade
|
| Return on Equity (ROE) | -9.10% | -25.25% | -21.42% | -24.35% | -5.05% | 145.07% | Upgrade
|
| Return on Assets (ROA) | -12.08% | -16.70% | -16.90% | -13.64% | -2.72% | 84.59% | Upgrade
|
| Return on Capital (ROIC) | -13.28% | -19.08% | -21.38% | -18.27% | -3.54% | 107.72% | Upgrade
|
| Return on Capital Employed (ROCE) | -26.00% | -33.50% | -31.00% | -29.10% | -4.60% | 82.20% | Upgrade
|
| Earnings Yield | -13.80% | -44.34% | -5.10% | -5.08% | -0.36% | 6.01% | Upgrade
|
| FCF Yield | -44.88% | -58.58% | -14.30% | -2.78% | 0.01% | 7.23% | Upgrade
|
| Dividend Yield | 41.02% | 50.26% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 22.32% | -8.66% | -3.58% | -1.32% | 3.31% | -1.14% | Upgrade
|
| Total Shareholder Return | 65.42% | 41.60% | -3.58% | -1.32% | 3.31% | -1.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.